ELV's Q2 EPS slides 12.6% y/y and misses estimates as rising Medicaid and ACA costs weigh on the results.
Elevance Health, Inc. (NYSE:ELV ) Q2 2025 Earnings Conference Call July 17, 2025 8:30 AM ET Company Participants Felicia Farr Norwood - Executive VP & President of Government Health Benefits Gail Koziara Boudreaux - President, CEO & Director Mark Bradley Kaye - Executive VP & CFO Morgan Kendrick - Corporate Participant Nathan Allen Rich - Vice President of Investor Relations Peter David Haytaian - Executive VP and President of Carelon & CarelonRx Conference Call Participants Albert J. William Rice - UBS Investment Bank, Research Division Andrew Mok - Barclays Bank PLC, Research Division Ann Kathleen Hynes - Mizuho Securities USA LLC, Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Benjamin Whitman Mayo - Leerink Partners LLC, Research Division David Howard Windley - Jefferies LLC, Research Division Erin Elizabeth Wilson Wright - Morgan Stanley, Research Division George Robert Hill - Deutsche Bank AG, Research Division Jason Paul Cassorla - Guggenheim Securities, LLC, Research Division Joshua Richard Raskin - Nephron Research LLC Justin Lake - Wolfe Research, LLC Kevin Mark Fischbeck - BofA Securities, Research Division Lance Arthur Wilkes - Sanford C.
While the top- and bottom-line numbers for Elevance Health (ELV) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
![]() ELV In 1 month Estimated | Quarterly | $1.71 Per Share |
![]() ELV 1 month ago Paid | Quarterly | $1.71 Per Share |
![]() ELV 4 months ago Paid | Quarterly | $1.71 Per Share |
![]() ELV 7 months ago Paid | Quarterly | $1.63 Per Share |
![]() ELV 10 months ago Paid | Quarterly | $1.63 Per Share |
![]() ELV 10 Jun 2024 Paid | Quarterly | $1.63 Per Share |
15 Oct 2025 (In 3 months) Date | | 8.64 Cons. EPS | - EPS |
22 Jul 2025 (In 5 days) Date | | 9.19 Cons. EPS | - EPS |
17 Jul 2025 17 Jul 2025 Date | | 9.01 Cons. EPS | - EPS |
15 Jul 2025 Date | | - Cons. EPS | - EPS |
16 Apr 2025 Date | | - Cons. EPS | - EPS |
![]() ELV In 1 month Estimated | Quarterly | $1.71 Per Share |
![]() ELV 1 month ago Paid | Quarterly | $1.71 Per Share |
![]() ELV 4 months ago Paid | Quarterly | $1.71 Per Share |
![]() ELV 7 months ago Paid | Quarterly | $1.63 Per Share |
![]() ELV 10 months ago Paid | Quarterly | $1.63 Per Share |
![]() ELV 10 Jun 2024 Paid | Quarterly | $1.63 Per Share |
15 Oct 2025 (In 3 months) Date | | 8.64 Cons. EPS | - EPS |
22 Jul 2025 (In 5 days) Date | | 9.19 Cons. EPS | - EPS |
17 Jul 2025 17 Jul 2025 Date | | 9.01 Cons. EPS | - EPS |
15 Jul 2025 Date | | - Cons. EPS | - EPS |
16 Apr 2025 Date | | - Cons. EPS | - EPS |
Medical - Healthcare Plans Industry | Healthcare Sector | Gail Koziara Boudreaux CEO | NYSE Exchange | 036752103 Cusip |
US Country | 104,200 Employees | 10 Mar 2025 Last Dividend | 1 Jun 2005 Last Split | 2 Jan 2001 IPO Date |
Elevance Health, Inc., operating in the United States, is a comprehensive health benefits organization that was established in 2001. Initially known as Anthem, Inc., the company underwent a name change to Elevance Health, Inc. in June 2022, marking a new era in its operation. Headquartered in Indianapolis, Indiana, Elevance Health extends its services through a range of health plans and insurance products. The company's operations are segmented into four main divisions: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other, reflecting its vast spectrum of offerings in the health sector. Elevance Health is a key player in the health benefits space, leveraging its extensive network and services to cater to the diverse needs of its program members.
Elevance Health provides a variety of health plans, including managed care services on a fee basis, catering to the needs of its members. This segment ensures access to quality healthcare and supports the wellbeing of individuals under its care.
Offering more than traditional health insurance, the company extends its portfolio to include stop loss, dental, vision, life, disability, and supplemental health insurance benefits. These products are designed to offer comprehensive coverage and peace of mind to members.
Under its CarelonRx segment, Elevance Health operates in the pharmacy services business, providing crucial services like pharmacy benefit management, home delivery and specialty pharmacies, formulary management, pharmacy networks, and rebate administration. This comprehensive approach ensures accessibility and affordability of prescription medications.
The company also excels in delivering a wide range of healthcare-related services, including but not limited to utilization management, behavioral health, integrated care delivery, and palliative care. Additionally, it offers payment integrity services, subrogation services, and health and wellness programs, emphasizing its commitment to overall health management and cost containment.
Through its involvement in the National Government Services business, Elevance Health plays a crucial role in servicing government health programs. This segment underscores the company's expertise and capacity to handle large-scale, government-sponsored health initiatives efficiently.
Elevance Health serves its clients under well-established brand names such as Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon, aligning its diverse service offerings with trusted and recognized brands in the health industry.